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INTRODUCTION
Paeonol (2'-hydroxy-4'-methoxyacetophenone), a micro-
molecular phenolic compound (Fig. 1), has been isolated from 
the root bark of the plant Paeonia moutan. Paeonol is tradi-
tionally used as a Chinese herbal medicine that has been wi-
dely used in sedation, hypnosis, antipyresis, analgesia, anti-
oxidation, anti-infl ammation, anti-bacterial and to activate the 
blood fl ow and remove blood stasis (Dai et al., 2000; Mimura 
and Baba, 2001; Chou, 2003; Zhang et al., 2011). Paeonol 
shows antitumor effects and inhibits the proliferation of differ-
ent tumor cell lines, e.g. the K562, T6-17, Bel-7404, Hela and 
HT-29 etc. Certain mechanisms of paeonol antitumor induce 
tumor cell apoptosis and enhance the activity of various im-
mune molecules. The induction of apoptosis was associated 
with a decrease of the ratio of Bcl-2/bax, an increase of fas/fasl 
and caspase 3 expression in HepA hepatoma mice (Pan et al., 
2004; Sun et al., 2008) and human esophageal cancer cell 
lines (Sun et al., 2004; Liu et al., 2005; Wan et al., 2008). The 
previous study confi rmed that paeonol inhibited the growth of 
tumor cells by reducing the expression of mutant p53, Bcl-2 
and C-erbB-2 proteins in tumor tissues in mice bearing EMT6 
breast cancer (Wang et al., 2010). No detailed report was car-
ried out on the mechanism of paeonol against breast cancer 
through the induction of apoptosis. Therefore, the present 
study further investigated the possible mechanisms respon-
sible for the antitumor activity of paeonol using EMT6 bearing 
mice. The purpose was to explore the therapeutic potential of 
paeonol for breast cancer and to provide a scientifi c expla-
nation for the traditional application of this particular herbal 
medicine in breast cancer therapy. 
Original Article
Biomol  Ther 22(4), 341-346 (2014)
*Corresponding Author
E-mail: jmsdxjianjie@163.com
Tel: +86-335-8074662, Fax: +86-335-8074662
Received Dec 16, 2013  Revised Jun 11, 2014  Accepted Jun 16, 2014
Published online Jul 31, 2014
http://dx.doi.org/10.4062/biomolther.2013.106
Copyright © 2014 The Korean Society of Applied Pharmacology
Open  Access
This is an Open Access article distributed under the terms of the Creative Com-
mons Attribution Non-Commercial License (http://creativecommons.org/licens-
es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
www.biomolther.org 
Paeonol is a major phenolic micromolecular component of Moutan cortex Radicis, a traditional Chinese Medicine. It has shown 
antitumor effects in previous studies; however, the underlying mechanisms remain unknown. This study investigated the mecha-
nism by giving treatments of placebo, cyclophosphamide, paeonol of 150 and 300 mg/kg to 4 groups of mice bearing EMT6 breast 
cancer. Apoptosis in tumor cells were confi rmed by morphology analysis, including hematoxylin, eosin staining and TUNEL stain-
ing. The results showed that the weight of EMT6 breast tumor was signifi cantly reduced in the groups treated with both 150 and 
300 mg/kg of paeonol. Immunohistochemical and Western blot results showed that the expression of Bcl-2 was down-regulated 
while the expression of Bax, caspase 8 and caspase 3 was up-regulated respectively. These results suggest that paeonol exhibits 
antitumor effects and the mechanism of the inhibition is via induction of apoptosis, regulation of Bcl-2 and Bax expression, and 
activation of caspase 8 and caspase 3.
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Abstract
Fig. 1. Molecular structure of paeonol.
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MATERIALS AND METHODS
Materials
Paeonol was obtained from Shenyang Pharmaceutical Uni-
versity (Shenyang, China). Cyclophosphamide (CTX) was 
purchased from HengRui pharmacy Inc. (Jiangsu Province, 
China). The terminal deoxyribonucleotide transferase-media-
ted nick-end labeling assays (TUNEL) kit was purchased 
from KeyGEN Bio. Tech. Co. Ltd (Nanjing, China). Strepta-
vidinbiotin Peroxidase immunohistochemical reagent kit was 
obtained from Beijing Zhongshan Biological Technology Co, 
Ltd. (Beijing, China). 3,3N-Diaminobenzidine Tertrahydrochlo-
ride (DAB) substrate kit was from Beyotime Institute Biotech-
nology (Shanghai, China). Mouse anti-Bcl-2, Bax, caspase 
8 and caspase 3 monoclonal antibodies were obtained from 
Santa Cruz Bio. Inc. (Santa Cruz, CA, USA). Horseradish 
pe roxidase-labeled rabbit antigoat IgG antibody and β-actin 
polyclonal antibody were purchased from Biosynthesis Bio. 
Co. (Beijing, China). The enhanced chemiluminescence kit 
was purchased from Amersham Pharmacia Biotech Co., Ltd 
(Sh anghai, China). Mouse breast cancer EMT6 cell line was 
ob tained from the Cancer Institute of the Chinese Academy of 
Medical Sciences. All other chemicals used were of analytical 
reagent grade.
Animals
Fifty female 6-week-old Kunming mice were purchased 
from the Laboratory Animal Center of the Academy of Military 
Me  dical Sciences. The mice were randomly divided into fi ve 
groups (n=10 per group). One group was used for the prepa-
ration of EMT6 tumor cells. The other four groups were used 
for different administrations (see details in the section: Animal 
model and drug treatment). Animals were housed in plastic 
cages with free access to food and water and maintained on 
a regulated environment (20 ± 2oC). All animal experiments 
were conducted in accordance with the NIH Guide for the 
Care and Use of Laboratory Animals (NIH Publication No.80-
23; revised 1978 and the number approved by Administrated-
Committee of Laboratory Animals was 062310).
Preparation of EMT6 tumor cells 
The EMT6 breast cancer cell line (107 cell/ml) was injected 
into the right forelimb in one group of mice (0.2 ml/mouse). 
When each tumor had grown to 1 cm in size, it was removed 
and suspended in normal saline to a concentration of 5×106 
cell/ml under aseptic conditions.
Animal model and drug treatment
Four groups of mice were all injected with 0.2 ml/mouse of 
5×106 cell/ml EMT6 breast cancer cells in the skin under the 
right forelimb. After 24h inoculation, one group was adminis-
tered with vehicle alone (distilled water, p.o.) as the control 
group. One group was given the standard antitumor reference 
drug cyclophosphamide (CTX, 25 mg/kg body weight, i.p.), 
which was designated as the positive control group, the CTX 
group. The other two groups were administrated paeonol, low 
dosage (150 mg/kg body weight, p.o.) and high dosage (300 
mg/kg body weight, p.o.). After 15 days, all mice were weighed 
and killed; each tumor was removed and weighed. According 
to the mean weight of the tumor, the rate of tumor inhibition 
was calculated as follows: the rate of inhibition (%)=[(mean 
tumor weight of Control group–mean tumor weight of Treated 
group)÷mean tumor weight of Control group]×100.
Morphological analysis of tumor tissues
Tumor specimens which were collected from the control 
group, CTX group and Paeonol group (300 mg/kg) were fi xed 
in 10% (v/v) neutral formalin solution, dehydrated through a 
graded ethanol series and embedded in paraffi n. Tissue sec-
tions (4 μm) were stained with hematoxylin and eosin and ex-
amined under the light microscope.
TUNEL assay 
Apoptotic cells in sections of mice tumor tissues from the 
four groups were detected by using an in situ apoptosis de-
tection kit according to the manufacturer’s instructions. Tissue 
sections were treated by dewaxing and hydration, fi rstly, ac-
cording to a conventional method, and then processed with 
10 mg/ml protease K for 30 minutes at room temperature. 
The slides were immersed in a 2% H2O2 solution to block en-
dogeneous peroxidase activity after rinsing 3 times in PBS. 
Terminal Deoxynucleotidyl Transferase (TdT) was used to 
ca talyze the addition of Biotin-conjugated dUTP to the 3’-OH 
ends of DNA fragments. 50 μl TdT enzyme reaction solution 
was added to each sample except for the control group and 
covered for 60 minutes at 37oC. After washing 3 times in PBS, 
50 μl Streptavidin-HRP solution was added and reacted for 
30 minutes at 37oC. Finally, DAB staining was carried out and 
apoptotic cells were detected under a light microscope.
Immunohistochemical analysis of Bcl-2, Bax and caspase- 
8 in tumor tissues
Tumor specimens which were collected from the four grou-
ps were fi xed in 10% (v/v) neutral formalin solution and em-
bedded in paraffi n. Tumor sections were prepared and used 
to examine the expression of Bcl-2, Bax and caspase-8 pro-
teins. The tumor sections were stained by the standard immu-
nohistochemical streptavidin peroxidase method which was 
described in the program of streptavidin peroxidasereagents 
kit. Previously known positive tumor tissues were used as a 
positive control for Bcl-2, Bax and caspase-8. The cells which 
stained brown suggest positive cells while cells stained blue 
indicate negative cells under the microscope. The immunohis-
tochemical results were quantitatively analyzed using a bio-
logical image analysis system and biological image analysis 
software (Leica Microsystems Ltd. Germany). The average 
positive rate was analyzed by microscopy using six randomly 
selected optical fi elds (200 cells per fi eld).
Western blot analysis for Bcl-2, Bax, caspase 8 and caspase 3
Tumor tissues from the four groups were minced and lysed 
in 500 μl cell lysis buffer for 30 minutes, and centrifuged at 
12,000 g for 15 minutes at 4°C. The supernatant was collected 
and protein concentrations were determined according to the 
Bradford method. Samples were subjected to 10% sodium do-
decyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) 
after which they were boiled for 5 minutes, and the resolved 
proteins were electrophoretically transferred to polyvinylide-
ne difl uoride membranes by a semi-dry transfer method. The 
membranes were blocked with 5% non-fat dried milk in Tris-
buffered saline containing 0.1% Tween 20 (TBST) for 1 hour at 
room temperature, washed three times with TBST, and incu-
bated with TBST containing 5% of dried skim milk and primary 
antibody (Bcl-2, Bax, caspase 8 or caspase 3) for 2 hours at 
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room temperature. After washing three times with TBST, the 
membranes were incubated with horseradish peroxidase-con-
jugated secondary antibody for 1 hour at room temperature. 
Proteins were visualized by using an enhanced chemilumine-
scence kit and exposed to X-ray fi lm. At the same time, actin 
was used as an internal control for all Western blots. The in-
tensity of protein bands was quantifi ed by using LabWork 3.0 
UVP software (UVP, Upland, CA, USA).
Statistical analysis
All values are expressed as mean ± S.D. One-way analysis 
of variance and Duncan’s multiple range tests were used for 
determining differences among groups, and p<0.05 was re-
garded as statistically signifi cant.
RESULTS
Cytotoxicity of paeonol on mice breast cancer
After tumor-bearing mice were treated with two dosages of 
paeonol 150 or 300 mg/kgbody weight and CTX for 15 days, 
there was no signifi cant infl uence on the body weight of mice 
in both CTX group and Paeonol group. However, comparing 
with the control group to the groups administered with paeonol 
of 150 mg/kg and 300 mg/kg the tumor weight signifi cantly 
decreased and the tumor inhibition rate was 41.25% and 
51.05%, respectively. CTX, which is the standard chemothera-
peutic, produced an inhibition rate of 53.84% (Table 1).
Morphological analysis of cell apoptosis 
Tumor cells in the control group were arranged closely in 
different shapes and sizes, the cells displayed a small cyto-
blastema and a larger nucleus which was thickly stained and 
obvious heteromorphism, and hyperplasia. As shown in Fig. 
2, the number of tumor cells in the Paeonol treatment groups 
decreased markedly, and tumor cell chromatin accumulated 
at the side of the nucleic membranes. The nucleic shapes 
were irregular and the surface of the nucleic membrane was 
rough. The nucleus was broken but it was encapsulated by 
intact membrane, containing intact organelles and apoptotic 
bodies. Comparing it with the Control group, there were more 
apoptotic cells in the Paeonol group under a light microscopy 
(Fig. 2). TUNEL staining results depicted that the apoptotic 
index reached 19.72% in the Paeonol group (300 mg/kg body 
weight) (Table 2, Fig. 3), this demonstrated that paeonol treat-
ment produced markedly more apoptotic cells. 
Eff ects of paeonol on the expression of Bcl-2, Bax and 
Caspase-8 
The S-P immunohistochemical method was used to exam-
Fig. 2. Morphological changes of tumors in the EMT6 model treated with paeonol (H&E stain, ×400). (A) The Control group. (B) CTX group. 
(C) Paeonol group (300 mg/kg body weight). White arrows indicate necrosis tumor cells and black arrows indicate apoptotic cells. The data 
was generated from six fi elds per slide, with four slides analyzed from each tumor, and 10 tumors examined from each group.
Table 1. The inhibitory effect of paeonol on EMT6 solid tumors (x  ±  s)
 Groups n Treatment (mg/kg)
Body weight (g)
Mean weight of tumor (g) Inhibition rate (%)
Start End
Control 10 Vehicle 20.23 ± 2.02 21.79 ± 2.23 2.86 ± 0.53 0 
CTX 10 25 21.48 ± 1.89 19.85 ± 1.34 1.32 ± 0.21a 53.84
Paeonol 10 150 20.69 ± 2.04 22.26 ± 2.85 1.68 ± 0.26a 41.25
10 300 21.38 ± 1.91 23.17 ± 2.34 1.40 ± 0.24a 51.05
ap<0.05 as compared with control group, values are mean ± S.D
Table 2. Effects of paeonol on the expression of Bcl-2, Bax, caspase 8 and apoptotic cells in tumor tissue (x  ±  s, %)
Groups Dose (mg/kg) Bcl-2 Bax Caspase-8 Apoptosis cells
Control Vehicle 69.38 ± 9.76 29.45 ± 5.47 36.29 ± 7.65 1.93 ± 1.62
CTX 25 46.22 ± 7.69a 49.26 ± 8.32a 54.37 ± 9.28a 6.73 ± 3.23a
Paeonol 150 37.54 ± 7.26a 57.62 ± 8.79a 61.23 ± 10.76a 10.78 ± 4.69a
300 27.63 ± 6.82a 63.77 ± 9.74a 78.65 ± 10.73a 19.72 ± 6.55a
ap<0.05 as compared with control group, values are mean ± S.D
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ine the expression of Bcl-2, Bax and Caspase-8. The results 
demonstrated that treatment with CTX and paeonol (300 mg/
kg body weight, administered orally) reduced the expression 
of Bcl-2, whereas increased the expression of Bax, and Cas-
pase-8. The percentage of Bcl-2 positive cells was 69.38% in 
the control group, whereas treatment with CTX and paeonol 
(300 mg/kg body weight, administered orally), the percentage 
of positive cells for Bcl-2 decreased to 46.22% in the CTX 
group and 27.63% in the paeonol group (Table 2, Fig. 4). 
The number of cells positive for Bax was 29.45 % in the con-
trol group, but the percentage of cells positive for Bax in the 
groups treated with CTX and paeonol increased signifi cantly 
to 49.26% and 63.77 %, respectively (Table 2, Fig. 5). The 
per centage of cells positive for Caspase-8 was 36.29 % in 
the control group. However, treatment with CTX and paeonol 
si gnifi cantly increased the number of Caspase-8 positive cells 
to 54.37% in the CTX group and 78.65% in Paeonol group 
(Table 2, Fig. 6). 
Eff ects of paeonol on the expression of Bcl-2, Bax, caspase 
8 and caspase 3 proteins by Western Blot
To further defi ne the effects of paeonol on tumor cells as-
sociated with the apoptotic pathway, protein levels of Bcl-2, 
Bax, caspase 8 and caspase 3 were evaluated by Western 
Blot. As shown in Fig. 7, the expression of Bcl-2 decreased 
no ticeably, whereas the protein expression of Bax, caspase 
8 and caspase 3 increased in the CTX and paeonol groups. 
Fig. 4. Effect of paeonol on the expression of Bcl-2 in EMT6 tumor tissues (S-P, ×400). (A) Control group, (B) CTX group, (C) Paeonol 
group (300 mg/kg). The data was generated from six fi elds per slide, with four slides analyzed from each tumor, and 10 tumors examined 
from each group.
Fig. 5. Effect of paeonol on the expression of Bax protein in EMT6 tumor tissues (S-P, ×400). (A) Control group; (B) CTX group; (C) Paeonol 
group (300 mg/kg). The data was generated from six fi elds per slide, with four slides analyzed from each tumor, and 10 tumors examined from 
each group.
Fig. 6. Effect of paeonol on the expression of caspase 8 in EMT6 tumor tissues. (S-P, ×400). (A) Control group, (B) CTX group, (C) Pae-
onol group (300 mg/kg). The data was generated from six fi elds per slide, with four slides analyzed from each tumor, and 10 tumors exam-
ined from each group.
Fig. 3. Morphological changes of apoptosis in vivo to EMT6 breast 
cancer model treated with paeonol. (A) Control group. (B) Paeonol 
group (300 mg/kg body weight). Black arrows indicate apoptotic 
cells. The data was generated from six fi elds per slide, with four 
slides analyzed from each tumor, and 10 tumors examined from 
each group (TUNEL stain, ×200).
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DISCUSSION
This study is further investigation into the effects and mech-
anisms of paeonol on mice harboring breast cancer cells. 
The results demonstrated that the paeonol plays an impor-
tant antitumor role. Compared with the control group, paeonol 
administration can signifi cantly decrease the tumor weight 
and increase the tumor inhibition rates; induce morphological 
changes indicative of apoptosis; increase tumor cell apopto-
sis; and regulate the expression of Bcl-2 and Bax, leading to a 
decrease of the ratio of Bcl-2/Bax; increase the activity of cas-
pase 8 and caspase 3. The fi ndings are consistent with previ-
ous studies using paeonol which showed Bcl-2 down-regula-
tion, Bax and caspase-3 activation in mouse HepA-hepatoma 
and human colon cancer cell lines (Sun et al., 2008; Li et al., 
2010; Xing et al., 2010). 
Apoptosis, also called programmed cell death, is an evolu-
tionarily conserved genetic program of cellular characteristics. 
It is well recognized that an alteration of the cellular homeosta-
sis occurs in cancer, which disrupts the balance between cel-
lular proliferation and cell death (apoptosis). Apoptosis is also 
a form of cell death which is characterized morphologically by 
extreme chromatin condensation and formation of apoptotic 
bodies (Zhang et al., 2008; Wang et al., 2012). Many anti-
cancer drugs induce tumor cell apoptosis which is an obvious 
strategy for cancer therapy. 
The mechanisms of apoptosis induced by drugs are com-
plex due to the differences in cell types and drugs (Li et al., 
2011). However, mitochondrial and cell-surface death recep-
tor-mediated apoptosis are the two principal pathways lead-
ing to programmed cell death. The mitochondrial pathway is 
thought to play a major role in response to cancer treatments 
and is mediated by the Bcl-2 family proteins, which are always 
over-expressed in many tumor cells (Reed, 2000; Sjöström et 
al., 2002; Ohtsuka et al., 2003) and they act as repressors of 
apoptosis by blocking the release of cytochrome-c, whereas 
proapoptotic members, e.g., Bax, act as promoters. These ef-
fects are more dependent on the balance between Bcl-2 and 
Bax than on Bcl-2 quantity alone.
In the current study, the treatment with paeonol decreased 
the expression of Bcl-2 and increased the expression of Bax. 
The up-regulation of Bax expression and the reduction of Bcl-
2 expression in the treated groups leads to a decrease in the 
ratio of Bcl-2 to Bax, which might be responsible for the drug-
induced apoptotic processes and which might be associated 
with better prognosis. 
Caspase 8, an initiator of apoptosis, could be activated un-
der the stimulation of external signals. Activated caspase 8 
continues to cleave procaspase 3 into active caspase 3 to ac-
hieve apoptosis. Caspase 3 is an executioner caspase of the 
apoptosis pathway (Mlejnek, 2001; Cheung et al., 2002). In 
the present study, after administration with paeonol there was 
Fig. 7. Western blot analysis for Bcl-2, Bax, caspase 8 and caspase-3 in tumor tissue. (A) Bcl-2, Bax, caspase 8 and caspase-3 expression 
by Western Blot method. β-actin was used as a control; data shown is representative of three independent experiments. (B) The intensity 
of Bcl-2 and Bax bands was quantifi ed and was shown as relative expression level after it was normalized by β-actin (n=3, mean  ±  S.D.); 
*p<0.05, vs. Control group. (C) the ratio of Bcl-2/Bax was shown. *p<0.05 vs. Control group. (D) The intensity of caspase 8 and caspase 3 
was quantifi ed and was shown as relative expression level after it was normalized by β-actin (n=3, mean  ±  S.D.). *p<0.05, vs. Control group.
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a considerable increase in caspase 8 and caspase 3 expres-
sions, which indicated that paeonol promoted caspase 8 and 
caspase 3 activation. 
The results of the study demonstrate that paeonol has the 
effect of inhibiting the growth of tumor cells. The mechanism of 
inhibition by inducing apoptosis could possibly occur through 
the triggering of the mitochondrial-dependent pathway and 
caspase activation. Paeonol, a traditional natural plant com-
pound, may be a novel chemotherapy against breast cancer. 
ACKNOWLEDGMENTS
Authors thank Mrs Sakina Ayub Ali and Miss Halima Ayub 
for their contribution and comments. 
REFERENCES 
Cheung, T. H., Chung, T. K., Lo, K. W., Yu, M. Y., Krajewski, S., Reed, 
J. C. and Wong, Y. F. (2002) Apotosis-related proteins in cervical in-
traepithelial neoplasia and squamous cell carcinoma of the cervix. 
Gynecol. Oncol. 86, 14-18.
Chou, T. C. (2003) Anti-infl ammatory and analgesic effects of paeonol 
in carrageenan-evoked thermal hyperalgesia. Br. J. Pharmacol. 
139, 1146-1152.
Dai, M., Liu, Q. Y., Gu, C. G. and Zhang, H. Y. (2000) Inhibitory effect of 
paeonol on lipid peroxidational reaction and oxidational decorate of 
low density lipoprotein. Zhongguo Zhong Yao Za Zhi 25, 625-627.
Li, K., Li, Q. W., Zhang, T., Han, Z. S., Li, J., Liu, Z. W. and Zheng, F. L. 
(2011) Procyanidins from Pinus koraiensis bark inhibits HeLa cell 
growth by inducing apoptosis and reducing survivin protein expres-
sion. Afr. J. Biotechnol. 40, 7766-7771.
Li, N., Fan, L. L., Sun, G. P., Wan, X. A., Wang, Z. G., Wu, Q. and 
Wang, H. (2010) Paeonol inhibits tumor growth in gastric cancer in 
vitro and in vivo. World J. Gastroenterol. 16, 4483-4490.
Liu, C. Q., Tan, S. Y., Ji, C. Y., Luo, H. S. and Yu, J. P. (2005) The ef-
fects of paeonol on inhibiting the proliferation of human colorectal 
cancer cell lines HT-29 and its molecular mechanism. Chin. Pharm. 
Bull. 21, 1251-1254.
Mimura, K. and Baba, S. (2001) Determination of paeonol metabo-
lites in man by the use of stable isotopes. Chem. Pharm. Bull. 29, 
2043-2050.
Mlejnek, P. (2001) Caspase inhibition and N6-benzyladenosine-in-
duced apoptosis in HL-60 cells. J. Cell Biochem. 83, 678-689.
Ohtsuka, T., Buchsbaum, D., Oliver, P., Makhija, S., Kimberly, R. and 
Zhou, T. (2003) Synergistic induction of tumor cell apoptosis by de-
ath receptor antibody and chemotherapy agent through JNK/p38 
and mitochondrial death pathway. Oncogene 22, 2034-2044. 
Pan, X. D., Fei, Q. Z., Zhu, C. G. and Liang, B. (2004) Synthesis of 
fi ve paeonol esters and their activity in vitro and in vivo anti-tumor. 
Anhui Medical and Pharmaceutical Journal 8, 16-18.
Reed, J. C. (2000) Mechanisms of apoptosis. Am. J. Pathol. 157, 
1415-1430.
Sjöström, J., Blomqvist, C., von Boguslawski, K., Bengtsson, N. O., 
Mjaaland, I., Malmström, P., Ostenstadt, B., Wist, E., Valvere, V., 
Takayama, S., Reed, J. C. and Saksela, E. (2002) The predictive 
value of Bcl-2, Bax, Bcl-xL, bag-1, fas and fasL for chemotherapy 
response in advanced breast cancer. Clin. Cancer Res. 8, 811-816.
Sun, G. P., Wan, X., Xu, S. P., Wang, H., Liu, S. H. and Wang, Z. G. 
(2008) Antiproliferation and apoptosis induction of paeonol in hu-
man esophageal cancer cell lines. Dis. Esophagus 21, 723-729.
Sun, G. P., Wang, H., Xu, S. P., Wu, Q., Chen, Z. D. and Wei, W. (2008) 
Anti-tumor effects of paeonol in a HepA- hepatoma bearing mouse 
model via induction of tumor cell apoptosis and stimulation of IL-2 
and TNF-α production. Eur. J. Pharmacol. 584, 246-252.
Sun, Y. C., Shen, Y. X., and Sun, G. P. (2004) Advances in the studies 
of major pharmacological activity of paeonol. Chin. Chin. Tradit. 
Pat. Med. 26, 579-582.
Xing, G., Zhang, Z., Liu, J., Hu, H. and Sugiura, N. (2010) Antitumor ef-
fect of extracts from moutan cortex on DLD-1 human colon cancer 
cells in vitro. Mol. Med. Report. 3, 57-61. 
Wan, X. A., Sun, G. P., Wang, H., Xu, S. P., Wang, Z. G. and Liu, S. H. 
(2008) Synergistic effect of paeonol and cisplatin on oesophageal 
cancer cell lines. Dig. Liver Dis. 40, 531-539.
Wang, J. J., Li, Q. W., Ou, Y. T., Li, C. J., Sun, X. X. and Tian, Y. Z. 
(2010) Antitumor effects of paeonol on mice bearing EMT6 breast 
infi ltrating ductal carcinoma. Lat. Am. J. Pharm. 5, 369-375. 
Wang, P. J., Li, Q. W., Li, K., Zhang, X. B., Han, Z. S., Wang, J. J., Gao, 
D. W. and Li, J. (2012) Betulinic acid exerts immunoregulation and 
anti-tumor effect on cervical carcinoma (U14) tumor-bearing mice. 
Pharmazie 67, 733-739.  
Zhang, H., Gao, M. and Yang, X. (2011) Electrochemical oxidation and 
detection of paeonol on modifi ed electrode with acetylene black 
nanoparticles. Colloids Surf B Biointerfaces 87, 378-381. 
Zhang, T., Li, Q. W., Li, K., Li, Y. R., Li, J., Wang, G. J. and Zhou, S. 
B. (2008) Antitumor effects of saponin extract from Patrinia villosa 
juss on mice bearing U14 cervical cancer. Phytother Res. 22, 640-
645.
